Healthcare organizations increasingly rely on community-based organizations to identify and screen eligible patients for specialized programs. Whether it's Enhanced Care Management, chronic disease programs, care coordination services, or population health initiatives, CBOs are often the front door. They're already working with your target populations and have the trust and relationships that clinical organizations struggle to build.
The business arrangement seems straightforward: pay the CBO when someone they screen successfully enrolls in your program. Simple, performance-based, and efficient.
Except here's the problem: that structure can look dangerously close to paying for referrals.
When Performance-Based Payments Become Kickbacks
In most industries, paying someone a fee for each customer they send your way is standard business practice. In healthcare, it's potentially a federal crime.
The Anti-Kickback Statute exists because financial incentives can distort medical decision-making. While your screening arrangement may not be about steering patients toward unnecessary procedures, regulators see something simpler: you're paying money tied directly to patient volume.
Without the right documentation and methodology, that payment per successful enrollment could be viewed as remuneration for referrals rather than compensation for services rendered. The distinction matters immensely. One is a legitimate business arrangement, the other is fraud.
So how do you structure a compliant payment when the commercial reality is that you only want to pay for successful outcomes?
The Fair Market Value Problem
The key to compliance is demonstrating that you're paying fair market value for actual services, not paying for referrals disguised as services. But determining FMV for screening arrangements is more complex than it appears.
FMV represents what a hypothetical willing buyer would pay a hypothetical willing seller for these services in an arm's-length transaction. It's not what you specifically might be willing to pay based on your program economics or unique circumstances.
This means building a valuation that's grounded in market-based assumptions about costs, conversion rates, and reasonable margins (not just your particular program's results).
What Goes Into a Screening?
On the surface, a screening seems simple: a case worker asks eligibility questions, explains a program, and submits information if the individual is interested and potentially qualified.
But the actual investment is more layered. There's direct staff time for the interaction itself: greeting the individual, building rapport, explaining benefits, asking questions, obtaining consent, and documenting everything. That staff member is typically a trained case manager, community health worker, or social services professional with real hourly costs.
Then there's upfront training before any screenings happen. Someone needs to educate CBO staff about eligibility criteria, program benefits, handling health information, and submission processes. That training investment needs to be allocated across future screenings.
There's also ongoing supervision and coordination: ensuring quality, maintaining communication between organizations, addressing issues. And depending on the program, follow-up activities like checking dashboards, reaching out to individuals who didn't respond to enrollment outreach, and providing additional information.
All of this represents real cost. The question is: what's the fair market value of that bundle of services?
The Conversion Rate Challenge
Here's where the economics get complicated. Your CBO partner might screen ten individuals, but only a portion will be eligible, interested, reachable, and successfully enrolled. The partner invested resources into all ten attempts, but you're only paying when someone enrolls.
This is why a "per screening attempt" payment often doesn't match the business relationship. It's administratively burdensome and doesn't align incentives. But a "per successful enrollment" payment needs to reflect the total work effort, including unsuccessful attempts.
This is where establishing a market conversion rate becomes critical. You're not simply using your specific program's actual conversion rate; that would make the FMV calculation circular. Instead, you need to determine what a reasonable market conversion rate would be for this type of screening activity, based on target population characteristics, screening methodology, and program requirements.
What conversion rate should a hypothetical buyer and seller reasonably expect when screening for programs targeting high-risk populations? What about programs requiring specific clinical criteria versus broader eligibility? The market-based rate you establish needs to be supportable through research and reasonable assumptions, not cherry-picked from your actual results.
Geographic and Market Context
A screening in a high-cost urban area requires the same effort as one in a lower-cost region, but labor costs are substantially different. Geographic cost adjustments aren't optional; they're necessary to avoid either overpaying or underpaying across different markets.
The methodology exists through established indices used for other healthcare payments, but applying it requires identifying appropriate benchmark data for the types of services and personnel involved in screening activities.
The Documentation Defense
The real test comes when you need to defend your payment structure. Can you demonstrate that your per-enrollment payment is based on fair market value of services rendered rather than the value of referrals generated?
This requires documented time requirements for each screening component, market wage data for relevant personnel, supportable conversion rate assumptions based on market research, and a clear methodology showing how these inputs translate into defensible FMV.
Critically, you need to show that your payment doesn't vary based on the volume or value of referrals. It's the same rate regardless of whether the enrolled patient is high-cost or low-cost. The payment is for the screening service, not for the referral value.
Why This Requires Rigor
Some organizations try to solve this by paying what seems reasonable or approximating what competitors might pay. But without the underlying methodology and documentation, these approaches don't hold up under scrutiny.
The compliance challenge isn't just about having a defensible payment amount. It's about having a defensible methodology that demonstrates your payment represents fair market value for services, not compensation for referrals. That requires understanding the economics of screening services, the regulatory framework around anti-kickback compliance, and the valuation principles that establish true FMV in a hypothetical market transaction.
Getting the Structure Right
Community partnerships can be extraordinarily valuable for population health programs and value-based care arrangements. CBOs often have relationships and trust with exactly the populations healthcare organizations struggle to reach.
But these partnerships need to be structured compliantly from the start. A payment arrangement that makes perfect business sense can create significant legal risk if it's not built on a defensible fair market value foundation.
The good news is that there are compliant ways to structure performance-based payments to community partners. It requires rigorous methodology, proper documentation, and understanding of both the regulatory landscape and FMV principles. But it's achievable (and necessary) if you want these partnerships to thrive without creating compliance exposure.